Wird geladen...
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus
Systemic delivery of therapeutics for treatment of lung diseases has several limitations including poor organ distribution of delivered payload with relatively low accumulation of active substances in the lungs and severe adverse side effects. In contrast, nanocarrier based therapeutics provide a br...
Gespeichert in:
| Veröffentlicht in: | Adv Ther (Weinh) |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7646027/ https://ncbi.nlm.nih.gov/pubmed/33173809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adtp.202000203 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|